Angelo G. Scopelianos, Ph.D.

Chief Research and Development Officer

Dr. Scopelianos has served as Axogen’s Chief Research and Development Officer since January 2021 and previously served as Vice President of Research and Development since September 2018. From 2012 until joining Axogen, Dr. Scopelianos was an independent consultant specializing in medical devices. He began consulting after his retirement from a 24-year tenure at Johnson & Johnson. Angelo began at Johnson & Johnson in 1988 as Section Manager of R&D and held the escalating positions of Manager of R&D, Director of R&D, Vice President of R&D and finally from October 2010 to September 2012 Senior Vice President of R&D. He joined J&J after research leadership positions at EI Dupont de Nemours in Wilmington, Delaware, and Pennwalt Corporation. Angelo received his doctorate degree in organic chemistry from Pennsylvania State University, following completion of a B.S. degree from the State University of New York-Oneonta. He holds over 35 U.S. patents and numerous international patents, and his awards include the Outstanding Science Alumni Award from Penn State University and the Scientific Leadership Award in Biomaterials Science awarded by a consortium of NJ research universities.